RxDoctor Payments Data

David Joyce, MD

Thoracic Surgery (Cardiothoracic Vascular Surgery) · Albuquerque, NMNPI 1558416115

Payments from drug & device makers

What this record shows

The money is spread across several categories — travel and lodging (27.7%), consulting fees and food and beverage — rather than concentrated in one kind of arrangement. 16 manufacturers reported payments, led by Paragonix Technologies, Inc. at 25.7% of the total. 2025 is the largest year on record at $6,125, more than ten times the $516 reported in 2019.

$19,464in general payments, 2019–2025

Across 132 payments — averaging $147.45 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Paragonix Technologies, Inc.$5K
  • Medtronic$4K
  • Abiomed$4K
  • Abbott$3K
  • Atricure, Inc.$1K
  • Livanova USA, Inc.$595
  • plus $1K from 10 others
$137,213in research payments, 2019–2025

Across 26 payments — averaging $5277.43 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Transmedics, Inc.$74K
  • Livanova USA, Inc.$63K

What the payments were for

  • Consulting fees$5,00026%
  • Speaking & faculty fees$4,15021%
  • Travel & lodging$5,39428%
  • Food & beverage$4,92025%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

Too few thoracic surgery (cardiothoracic vascular surgery) providers in New Mexicoto place this figure against a meaningful peer group, so we don't.

Medicare billing

Part B allowed, 2024
$52,778
Medicare patients
49
Services billed
109

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other thoracic surgery (cardiothoracic vascular surgery) in Albuquerque

See the full list for New Mexico

Where these figures come from

Is this you, or does something look wrong? →